A = doxorubicin; CMF = cyclophosphamide, methotrexate and 5- fluorouracil; D = docetaxel; FEC = 5-fluorouracil, epirubicin and cyclophosphamide; P = paclitaxel; T = trastuzumab. pCR was defined
Objective: To explore the use and safety of penpulimab in real world. Methods: Totally 13 inpatients using penpulimab were observed from April to December 2022 in a cancer hospital. The data of patien
Infusion-related complaints during or the first 24 hours after infusion, and side-effects during 12 months follow-up, in the Rituximab and Placebo groups.
In this study, we aimed to evaluate axillary lymph node dissection (ALND) rates and prognosis in neoadjuvant chemotherapy (NCT) compare with neoadjuvant endocrine therapy (NET) in estrogen receptor-po
